| Invasive treatment group |  | Non-invasive treatment group | ||||||
---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | ||||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | ||
Age, year | 0.994 (0.953, 1.038) | 0.799 | – | – | BMI | 0.889 (0.796, 0.993) | 0.037 | 0.948 (0.851,1.055) | 0.327 |
BMI | 0.945 (0.816, 1.095) | 0.452 | 1.007 (0.892, 1.136) | 0.913 | Cr (µmol/L) | 1.017 (1.006, 1.028) | 0.002 | 1.012 (0.998, 1.025) | 0.089 |
Systolic BP (mmHg) | 0.963 (0.930, 0.997) | 0.031 | 0.978 (0.942,1.016) | 0.255 | Uric acid (µmol/L) | 1.006 (1.003, 1.009) |  < 0.001 | 1.004 (1.002,1.007) | 0.002 |
Diastolic BP (mmHg) | 0.951 (0.903, 1.002) | 0.059 | – | – | Triglyceride (mg/dl) | 0.990 (0.982,0.999) | 0.022 | – | – |
Cr (µmol/L) | 1.008 (0.989, 1.028) | 0.407 | – | – | LDL-C (mmol/L) | 0.807 (0.501,1.301) | 0.38 | – | – |
Uric acid (µmol/L) | 1.002 (1.000, 1.005) | 0.091 | – | – | HDL-C (mmol/L) | 0.175 (0.038,0.806) | 0.025 | 0.144 (0.032,0.654) | 0.012 |
Blood potassium level (mmol/L) | 1.325 (0.364,4.818) | 0.669 | – | – | HbA1c (%) | 2.430 (0.668,8.847) | 0.178 | – | – |
h-CRP(mg/L) | 0.932 (0.861, 1.008) | 0.078 | – | – | Fasting blood glucose(mg/dl) | 0.977 (0.943,1.012) | 0.198 | – | – |
Triglyceride (mg/dl) | 0.996 (0.986,1.005) | 0.366 | – | – | Hypertension | 0.754 (0.338,1.678) | 0.488 | – | – |
HDL(mmol/L) | 1.556 (0.341,7.113) | 0.568 | – | – | Dyslipidemia | 0.649 (0.279,1.505) | 0.314 | – | – |
HbA1c (%) | 1.441 (0.230,9.046) | 0.697 | – | – | TyG index | 0.393 (0.177,0.873) | 0.022 | 0.179 (0.063, 0.508) | 0.001 |
Fasting blood glucose(mg/dl) | 0.979 (0.944,1.015) | 0.252 | – | – |  |  |  |  |  |
Dyslipidemia | 1.209 (0.344,4.250) | 0.768 | – | – |  |  |  |  |  |
TyG index | 0.249 (0.079,0.791) | 0.018 | 0.215 (0.051, 0.902) | 0.036 | Â | Â | Â | Â | Â |